CXI Healthcare Technology Group Limited (KOSDAQ: 900120)

Market Cap	23.64B
Revenue (ttm)	67.19B
Net Income (ttm)	21.01B
Shares Out	288.23M
EPS (ttm)	97.34
PE Ratio	0.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	985,571
Open	84.00
Previous Close	84.00
Day's Range	82.00 - 87.00
52-Week Range	76.00 - 154.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2024

About CXI Healthcare Technology Group

CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It primarily offers Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 and is based in Grand Cayman, the Cayman Islands.

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 10
• Stock Exchange: KOSDAQ
• Ticker Symbol: 900120

Financial Performance

In 2023, CXI Healthcare Technology Group's revenue was 71.62 billion, a decrease of -29.35% compared to the previous year's 101.38 billion. Earnings were 7.53 billion, an increase of 25.85%.